|
|
|
Volumn 4, Issue 11, 1998, Pages 2573-2575
|
|
Therapeutic innovation: The up-front window: Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
TOPOTECAN;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
EDITORIAL;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
THERAPY RESISTANCE;
TREATMENT PLANNING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHILD;
CLINICAL TRIALS;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
METHOTREXATE;
TOPOTECAN;
|
|
EID: 0031756062
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (5)
|
|
References (20)
|
